Silvia Tiberti

6PUBLICATIONS
73CO-AUTHORS
Cell and nuclear divisionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
Mitochondrial Complex I at the Crossroads of NK cell Dysfunction in Glioblastoma.

|Apr 22, 2026
CAR-NK cell therapy for hematological malignancies.

|Mar 27, 2026
Palmitate-induced mitochondrial damage restricts histone acetylation in CD8 T cells to impair antitumor immunity.

Silvia Tiberti, Sara Gennari, Martina Romeo

|Jun 04, 2025
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.

Hind Rafei, Rafet Basar, Sunil Acharya

|Sep 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Bijender Kumar, Anand Singh, Rafet Basar

|Aug 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.

Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi

Pageof 1

Frequent Collaborators

3 joint publications

May Daher

3 joint publications

Katayoun Rezvani

3 joint publications

Rafet Basar

2 joint publications

Sunil Acharya